British journal of clinical pharmacology

Keyphrases

Publications

2023

Jacqueline Wen Hui Leow, Xiao Jun Ang, Eric Chun Yong Chan
Development and verification of a physiologically based pharmacokinetic model of dronedarone and its active metabolite N-desbutyldronedarone: Application to prospective simulation of complex drug-drug interaction with rivaroxaban. British journal of clinical pharmacology (2023)
Yong Jin Lim, Steven G Xiu, M Sara Kuruvilla, Eric Winquist, Stephen Welch, Morgan Black, Lauren N Faught, Jasmine Lee, Michael J Rieder, Tom D Blydt-Hansen, Michael Zappitelli, Bradley L Urquhart
Metabolomic identification of predictive and early biomarkers of cisplatin-induced acute kidney injury in adult head and neck cancer patients. British journal of clinical pharmacology (2023)
Xin-Mei Yang, Pan-Pan Ye, Xiao-Lin Liu, Zi-Xuan Guo, Min Kan, Qian Li, Lin-Lin Song, Hong-Ying Liu, Ke-Guang Chen, Jin-Yi Shi, Ye-Hui Zhang, Ya Li, Fu-Rong Zhao, John van den Anker, Yan Li, Wei Zhao
Population Pharmacokinetics and Pharmacogenetics of Apatinib in Adult Cancer Patients. British journal of clinical pharmacology (2023)
Jane Ellen Carland, Alexandra E Stacy, Andrea L Schaffer, Richard Osborne Day, Jonathan Brett, Stephanie E Reuter, Sophie Lena Stocker
Blood, dose recommendation reports and phone calls - Experiences of a Therapeutic Drug Monitoring Advisory Service for vancomycin. British journal of clinical pharmacology (2023)
Vida Terzić, Léa Levoyer, Mélanie Figarella, Elisabetta Bigagli, Noémie Mercier, Lucie De Gastines, Séverine Gibowski, Marius Trøseid, Jacques Demotes, Inge Christoffer Olsen, Maya Hites, Florence Ader, José Ramón Arribas Lopez, France Mentré, Hélène Espérou, Dominique Costagliola, John-Arne Røttingen, Julien Poissy, Jean-Christophe Rozé, Adilia Warris, Jackie O'Leary, Ricardo M Fernandes, Lambert Assoumou, Regis Hankard, Mark A Turner, Yazdan Yazdanpanah, Alpha Diallo, null null, null null
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. British journal of clinical pharmacology (2023)
Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, Hannah Gunter, Chandni Patel, Eithne Costello, Daniel F Carr, Gary Maartens, Munir Pirmohamed, Christopher E P Goldring, Karen Cohen
Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injury. British journal of clinical pharmacology (2023)
Yong Jin Lim, Steven G Xiu, M Sara Kuruvilla, Eric Winquist, Stephen Welch, Morgan Black, Lauren N Faught, Jasmine Lee, Michael J Rieder, Tom D Blydt-Hansen, Michael Zappitelli, Bradley L Urquhart
Metabolomic Identification of Predictive and Early Biomarkers of Cisplatin-induced Acute Kidney Injury in Adult Head and Neck Cancer Patients. British journal of clinical pharmacology (2023)
Minna Lehtisalo, Wilma Kiander, Anne M Filppula, Feng Deng, Heidi Kidron, Mari Korhonen, Johanna Sinkko, Kimmo Koivula, Mikko Niemi
Rhabdomyolysis during concomitant ticagrelor and rosuvastatin - a breast cancer resistance protein -mediated drug interaction? British journal of clinical pharmacology (2023)
Li Rong, Mengyuan Xie, Manxue Jiang, Hongyu Qiu, Lingti Kong
A post-marketing pharmacovigilance study of avapritinib: Adverse event data mining and analysis based on the United States Food and Drug Administration Adverse Event Reporting System database. British journal of clinical pharmacology (2023)
Toshinori Hirai, Yoshihiko Morikawa, Ritsuki Onishi, Yusuke Nakatani, Kouhei Nishikawa, Takahiro Inoue, Takuya Iwamoto
Impact of glycemic control and CYP3A5 polymorphisms on tacrolimus trough concentrations after adult kidney transplantation. British journal of clinical pharmacology (2023)
Rena J Eudy-Byrne, Matthew M Riggs, Amale Hawi, Thomas Sciascia, Shashank Rohatagi
A Population Pharmacokinetic-Pharmacodynamic Model Evaluating Efficacy of Nalbuphine Extended-Release in Patients with Prurigo Nodularis. British journal of clinical pharmacology (2023)
Rena J Eudy-Byrne, Matthew M Riggs, Amale Hawi, Thomas Sciascia, Shashank Rohatagi
A population pharmacokinetic-pharmacodynamic model evaluating efficacy of nalbuphine extended-release in patients with prurigo nodularis. British journal of clinical pharmacology (2023)
Bérénice Manczak, Marie-Clémence Verdier, Joseph P Dewulf, Florian Lemaitre, Vincent Haufroid, Philippe Hantson
LACTIC ACIDOSIS AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION POTENTIALLY RELATED TO LETERMOVIR. British journal of clinical pharmacology (2023)
Nicholas A White, Timo J C Oude Vrielink, Koen E A van der Bogt, Adam F Cohen, Joris I Rotmans, Tim Horeman
Question-based development of high-risk medical devices: A proposal for a structured design and review process. British journal of clinical pharmacology (2023)
Fengshan Li, Hongda Lin, Lingli Zhang, Sheng Feng, Shiyin Feng, Xiaohong Liu, Linrui Cai, Zhuo Chen, Qin Zou, Yiwen Wu, Xu Su, Kai Shen, Qin Yu
A Phase I, Single-sequence, Open-label Study to Evaluate the Drug-Drug Interaction Between Hetrombopag and Cyclosporine in Healthy Chinese Subjects. British journal of clinical pharmacology (2023)
Tamara L Wexler, Gabrielle Page-Wilson
Dopamine Agonists for the Treatment of Pituitary Tumors: From Ergot Extracts to Next Generation Therapies. British journal of clinical pharmacology (2023)
Xin-Mei Yang, Pan-Pan Ye, Xiao-Lin Liu, Zi-Xuan Guo, Min Kan, Qian Li, Lin-Lin Song, Hong-Ying Liu, Ke-Guang Chen, Jin-Yi Shi, Ye-Hui Zhang, Ya Li, Fu-Rong Zhao, John van den Anker, Yan Li, Wei Zhao
Population pharmacokinetics and pharmacogenetics of apatinib in adult cancer patients. British journal of clinical pharmacology (2023)
Vincent Aketch Nyangwara, Tinashe Mazhindu, Zedias Chikwambi, Collen Masimirembwa, Thomas B Campbell, Margaret Borok, Ntokozo Ndlovu
CARDIOTOXICITY AND PHARMACOGENETICS OF DOXORUBICIN IN BLACK ZIMBABWEAN BREAST CANCER PATIENTS. British journal of clinical pharmacology (2023)
Saskia J Rietjens, Tessa E van Riemsdijk, Maaike A Sikma, Dylan W de Lange
High-dose insulin should NOT be used without vasopressors in calcium channel blocker toxicity. British journal of clinical pharmacology (2023)
Francisco Martínez-Mardones, Shalom I Benrimoj, Antonio Ahumada-Canale, Jose C Plaza-Plaza, Victoria García-Cárdenas
Clinical Impact of medication reviews with follow-up in cardiovascular older patients in primary care: a cluster-randomised controlled trial. British journal of clinical pharmacology (2023)
Muhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, Hannah Gunter, Chandni Patel, Eithne Costello, Dan Carr, Gary Maartens, Daniel F Carr, Christopher Goldring, Karen Cohen
Analysis of serum microRNA-122 in a randomised controlled trial of N-acetylcysteine for treatment of anti-tuberculosis drug-induced liver injury. British journal of clinical pharmacology (2023)
Mahmoud Ines, Myriam Moalla, Ben Tekaya Aicha, Charfi Rim, Rouached Leila, Bouden Selma, Tekaya Rawdha, Saidane Olfa, Abdelmoula Leila, Sfar Imen
Assessment of the influence of Fc gamma receptors polymorphisms on biologics' pharmacokinetics in Tunisian rheumatoid arthritis patients. British journal of clinical pharmacology (2023)

volume 89, number 3, 2023

Joshua Koslover, Deborah Bruce, Shivani Patel, Andrew James Webb
Metformin-'BRAINS & AIMS' pharmacological/prescribing principles of commonly prescribed (Top 100) drugs: Education and discussion. British journal of clinical pharmacology 89 (3) (2023)
Satoru Mitsuboshi, Kazumasa Kotake
Association between use of febuxostat and muscle injury: A disproportionality analysis and meta-analysis of randomized controlled trials. British journal of clinical pharmacology 89 (3) (2023)
Andrew James Webb
Introduction to the "BRAINS & AIMS" series of pharmacological/prescribing principles of commonly prescribed (top 100) drugs: Education and discussion. British journal of clinical pharmacology 89 (3) (2023)
Satoru Mitsuboshi, Kazumasa Kotake
Association between use of febuxostat and muscle injury: A disproportionality analysis and meta-analysis of randomized controlled trials. British journal of clinical pharmacology 89 (3) (2023)
Joshua Koslover, Deborah Bruce, Shivani Patel, Andrew James Webb
Metformin-'BRAINS & AIMS' pharmacological/prescribing principles of commonly prescribed (Top 100) drugs: Education and discussion. British journal of clinical pharmacology 89 (3) (2023)
Finsterer Josef
Post-COVID vaccination Guillain-Barre syndrome. British journal of clinical pharmacology 89 (3) (2023)
Finsterer Josef
Post-COVID vaccination Guillain-Barre syndrome. British journal of clinical pharmacology 89 (3) (2023)
Andrew James Webb
Introduction to the "BRAINS & AIMS" series of pharmacological/prescribing principles of commonly prescribed (top 100) drugs: Education and discussion. British journal of clinical pharmacology 89 (3) (2023)
Qing Wang, Zi-Yang Wu, Hui-Lin Tang, Zhan-Miao Yi, Suo-di Zhai
The efficacy and safety of prophylactic antibiotics for post-acute stroke infection: A systematic review and meta-analysis. British journal of clinical pharmacology 89 (3) (2023)
Joshua Koslover, Deborah Bruce, Shivani Patel, Andrew James Webb
Metformin-'BRAINS & AIMS' pharmacological/prescribing principles of commonly prescribed (Top 100) drugs: Education and discussion. British journal of clinical pharmacology 89 (3) (2023)
Satoru Mitsuboshi, Kazumasa Kotake
Association between use of febuxostat and muscle injury: A disproportionality analysis and meta-analysis of randomized controlled trials. British journal of clinical pharmacology 89 (3) (2023)
Qing Wang, Zi-Yang Wu, Hui-Lin Tang, Zhan-Miao Yi, Suo-di Zhai
The efficacy and safety of prophylactic antibiotics for post-acute stroke infection: A systematic review and meta-analysis. British journal of clinical pharmacology 89 (3) (2023)

volume 89, number 4, 2023

Tamara L Wexler, Gabrielle Page-Wilson
Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies. British journal of clinical pharmacology 89 (4) (2023)
Anthia Monribot, Olivier Huillard, Nihel Khoudour, Laure-Hélène Préta, Benoit Blanchet, Laure Cabanes, Rui Batista, Nicolas Pallet, Laurent Chouchana, François Goldwasser, Philippe Sogni, Audrey Thomas-Schoemann
Cardiac toxicity associated with pharmacokinetic drug-drug interaction between crizotinib and sofosbuvir/velpatasvir: A case report. British journal of clinical pharmacology 89 (4) (2023)
Cinzia Dello Russo, Pierluigi Navarra
What is the weight of expectation bias in oncology trials? British journal of clinical pharmacology 89 (4) (2023)
Vida Terzić, Léa Levoyer, Mélanie Figarella, Elisabetta Bigagli, Noémie Mercier, Lucie De Gastines, Séverine Gibowski, Marius Trøseid, Jacques Demotes, Inge Christoffer Olsen, Maya Hites, Florence Ader, José Ramón Arribas Lopez, France Mentré, Hélène Espérou, Dominique Costagliola, John-Arne Røttingen, Julien Poissy, Jean-Christophe Rozé, Adilia Warris, Jackie O'Leary, Ricardo M Fernandes, Lambert Assoumou, Regis Hankard, Mark A Turner, Yazdan Yazdanpanah, Alpha Diallo, null null, null null
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. British journal of clinical pharmacology 89 (4) (2023)
Bruno Mégarbane
High-dose insulin should be used before vasopressors/inotropes in calcium-channel blocker toxicity. British journal of clinical pharmacology 89 (4) (2023)
Saskia J Rietjens, Tessa E van Riemsdijk, Maaike A Sikma, Dylan W de Lange
High-dose insulin should NOT be used without vasopressors in calcium channel blocker toxicity. British journal of clinical pharmacology 89 (4) (2023)
Masaru Samura, Keisuke Takada, Naoki Hirose, Takenori Kurata, Fumio Nagumo, Masaki Uchida, Junki Inoue, Koji Tanikawa, Yuki Enoki, Kazuaki Taguchi, Kazuaki Matsumoto, Takashi Ueda, Shigeru Fujimura, Hiroshige Mikamo, Yoshio Takesue, Kotaro Mitsutake
Comparison of the efficacy and safety of standard- and high-dose daptomycin: A systematic review and meta-analysis. British journal of clinical pharmacology 89 (4) (2023)
Anthia Monribot, Olivier Huillard, Nihel Khoudour, Laure-Hélène Préta, Benoit Blanchet, Laure Cabanes, Rui Batista, Nicolas Pallet, Laurent Chouchana, François Goldwasser, Philippe Sogni, Audrey Thomas-Schoemann
Cardiac toxicity associated with pharmacokinetic drug-drug interaction between crizotinib and sofosbuvir/velpatasvir: A case report. British journal of clinical pharmacology 89 (4) (2023)
Behnam Amani, Bahman Amani
Efficacy and safety of regdanvimab in patients with mild to moderate COVID-19: A rapid review and meta-analysis. British journal of clinical pharmacology 89 (4) (2023)
Cinzia Dello Russo, Pierluigi Navarra
What is the weight of expectation bias in oncology trials? British journal of clinical pharmacology 89 (4) (2023)
Bruno Mégarbane
High-dose insulin should be used before vasopressors/inotropes in calcium-channel blocker toxicity. British journal of clinical pharmacology 89 (4) (2023)
Tamara L Wexler, Gabrielle Page-Wilson
Dopamine agonists for the treatment of pituitary tumours: From ergot extracts to next generation therapies. British journal of clinical pharmacology 89 (4) (2023)
Saskia J Rietjens, Tessa E van Riemsdijk, Maaike A Sikma, Dylan W de Lange
High-dose insulin should NOT be used without vasopressors in calcium channel blocker toxicity. British journal of clinical pharmacology 89 (4) (2023)
Masaru Samura, Keisuke Takada, Naoki Hirose, Takenori Kurata, Fumio Nagumo, Masaki Uchida, Junki Inoue, Koji Tanikawa, Yuki Enoki, Kazuaki Taguchi, Kazuaki Matsumoto, Takashi Ueda, Shigeru Fujimura, Hiroshige Mikamo, Yoshio Takesue, Kotaro Mitsutake
Comparison of the efficacy and safety of standard- and high-dose daptomycin: A systematic review and meta-analysis. British journal of clinical pharmacology 89 (4) (2023)
Behnam Amani, Bahman Amani
Efficacy and safety of regdanvimab in patients with mild to moderate COVID-19: A rapid review and meta-analysis. British journal of clinical pharmacology 89 (4) (2023)
Vida Terzić, Léa Levoyer, Mélanie Figarella, Elisabetta Bigagli, Noémie Mercier, Lucie De Gastines, Séverine Gibowski, Marius Trøseid, Jacques Demotes, Inge Christoffer Olsen, Maya Hites, Florence Ader, José Ramón Arribas Lopez, France Mentré, Hélène Espérou, Dominique Costagliola, John-Arne Røttingen, Julien Poissy, Jean-Christophe Rozé, Adilia Warris, Jackie O'Leary, Ricardo M Fernandes, Lambert Assoumou, Regis Hankard, Mark A Turner, Yazdan Yazdanpanah, Alpha Diallo, null null, null null
Implementation of a centralized pharmacovigilance system in academic pan-European clinical trials: Experience from EU-Response and conect4children consortia. British journal of clinical pharmacology 89 (4) (2023)